[go: up one dir, main page]

BG50834A3 - Method for the preparation of 3- acyl- 2- oxindole- 1- carboxamides - Google Patents

Method for the preparation of 3- acyl- 2- oxindole- 1- carboxamides

Info

Publication number
BG50834A3
BG50834A3 BG090022A BG9002289A BG50834A3 BG 50834 A3 BG50834 A3 BG 50834A3 BG 090022 A BG090022 A BG 090022A BG 9002289 A BG9002289 A BG 9002289A BG 50834 A3 BG50834 A3 BG 50834A3
Authority
BG
Bulgaria
Prior art keywords
oxindole
carboxamides
acyl
preparation
general formula
Prior art date
Application number
BG090022A
Other languages
Bulgarian (bg)
English (en)
Inventor
Thomas Crawford
Lawrence Reiter
Original Assignee
Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware filed Critical Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Publication of BG50834A3 publication Critical patent/BG50834A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG090022A 1988-10-18 1989-10-16 Method for the preparation of 3- acyl- 2- oxindole- 1- carboxamides BG50834A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1988/003658 WO1990004393A1 (en) 1988-10-18 1988-10-18 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides

Publications (1)

Publication Number Publication Date
BG50834A3 true BG50834A3 (en) 1992-11-16

Family

ID=22208957

Family Applications (1)

Application Number Title Priority Date Filing Date
BG090022A BG50834A3 (en) 1988-10-18 1989-10-16 Method for the preparation of 3- acyl- 2- oxindole- 1- carboxamides

Country Status (33)

Country Link
US (1) US5118703A (no)
JP (1) JPH07597B2 (no)
KR (1) KR910007237B1 (no)
CN (1) CN1022241C (no)
AP (1) AP118A (no)
AR (1) AR246519A1 (no)
AT (1) ATE125794T1 (no)
AU (1) AU606819B2 (no)
BG (1) BG50834A3 (no)
CA (1) CA1339558C (no)
CZ (1) CZ278983B6 (no)
DD (1) DD285604A5 (no)
DK (1) DK514989A (no)
EG (1) EG19887A (no)
FI (1) FI95253C (no)
HU (1) HU208421B (no)
IE (1) IE66586B1 (no)
IL (1) IL91960A (no)
IS (1) IS1598B (no)
MA (1) MA21657A1 (no)
MX (1) MX18021A (no)
MY (1) MY104238A (no)
NO (1) NO178027C (no)
NZ (1) NZ231044A (no)
OA (1) OA09140A (no)
PH (1) PH27554A (no)
PL (2) PL163112B1 (no)
PT (1) PT92000B (no)
RO (1) RO109195B1 (no)
RU (1) RU2036905C1 (no)
SK (1) SK278175B6 (no)
WO (1) WO1990004393A1 (no)
YU (1) YU48070B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
CZ131695A3 (en) * 1992-11-23 1996-05-15 Pfizer Process for preparing 4-chloro-2-thiophenecarboxylic acid, intermediates for its preparation and process for preparing 5-fluoro-6-chloro-3-(4-chloro-2-thenoyl)-2-oxindole-1-carboxamide
US5270331A (en) * 1993-01-26 1993-12-14 Pfizer, Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
JP2709530B2 (ja) * 1993-02-09 1998-02-04 ファイザー・インク. 抗炎症薬としてのオキシンドール1−[n−(アルコキシカルボニル)]カルボキサミド類および1−(n−カルボキサミド)カルボキサミド類
US5449788A (en) * 1994-01-28 1995-09-12 Catalytica, Inc. Process for preparing 2-oxindole-1-carboxamides
CN1094819C (zh) * 1997-04-30 2002-11-27 大兴株式会社 环状坯料之制造装置
EP0984012A3 (en) * 1998-08-31 2001-01-10 Pfizer Products Inc. Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties
CA2386889A1 (en) * 1999-10-26 2001-05-03 The University Of Texas Southwestern Medical Center Methods of treating hair loss comprising administering indoline compound

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL96047C (no) * 1956-06-08
US3564009A (en) * 1966-01-13 1971-02-16 Sumitomo Chemical Co Process for producing 1-acylindole derivatives
BE756447A (fr) * 1969-10-15 1971-03-22 Pfizer Oxindolecarboxamides
US3923996A (en) * 1972-07-31 1975-12-02 Sandoz Ag 3-Substituted-oxindoles in compositions and methods of treating obesity
IE53102B1 (en) * 1981-05-12 1988-06-22 Ici Plc Pharmaceutical spiro-succinimide derivatives
DE3268971D1 (en) * 1981-10-06 1986-03-20 Ici Plc Biochemical process
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4752609A (en) * 1985-06-20 1988-06-21 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
WO1988005656A1 (en) * 1987-02-02 1988-08-11 Pfizer Inc. Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
DE68923673T2 (de) * 1988-10-18 1996-01-18 Pfizer Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden.
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides

Also Published As

Publication number Publication date
RU2036905C1 (ru) 1995-06-09
PH27554A (en) 1993-08-18
IS1598B (is) 1996-05-20
SK590689A3 (en) 1996-03-06
HU208421B (en) 1993-10-28
NO178027C (no) 1996-01-10
OA09140A (fr) 1991-10-31
YU200589A (en) 1991-02-28
AU4295689A (en) 1990-04-26
YU48070B (sh) 1997-01-08
CZ278983B6 (en) 1994-11-16
DD285604A5 (de) 1990-12-19
JPH07597B2 (ja) 1995-01-11
CN1022241C (zh) 1993-09-29
KR900006285A (ko) 1990-05-07
PL163112B1 (pl) 1994-02-28
MX18021A (es) 1993-11-01
CA1339558C (en) 1997-11-25
NO178027B (no) 1995-10-02
IE66586B1 (en) 1996-01-24
JPH02149559A (ja) 1990-06-08
IL91960A0 (en) 1990-07-12
IS3509A7 (is) 1990-04-19
MY104238A (en) 1994-02-28
PL162316B1 (pl) 1993-09-30
CZ590689A3 (en) 1994-04-13
AP118A (en) 1991-02-22
DK514989D0 (da) 1989-10-17
EG19887A (en) 1996-03-31
HU886740D0 (en) 1991-07-29
NO911512D0 (no) 1991-04-17
PT92000A (pt) 1990-04-30
CN1041938A (zh) 1990-05-09
RO109195B1 (ro) 1994-12-30
PT92000B (pt) 1995-06-30
FI95253C (fi) 1996-01-10
AR246519A1 (es) 1994-08-31
US5118703A (en) 1992-06-02
KR910007237B1 (ko) 1991-09-24
SK278175B6 (en) 1996-03-06
WO1990004393A1 (en) 1990-05-03
FI95253B (fi) 1995-09-29
FI911855A0 (fi) 1991-04-17
AU606819B2 (en) 1991-02-14
ATE125794T1 (de) 1995-08-15
NO911512L (no) 1991-06-12
AP8900141A0 (en) 1989-10-31
DK514989A (da) 1990-04-19
HUT58052A (en) 1992-01-28
IE893332L (en) 1990-04-18
NZ231044A (en) 1990-12-21
IL91960A (en) 1994-04-12
MA21657A1 (fr) 1990-07-01

Similar Documents

Publication Publication Date Title
BG49825A3 (en) Method for preparing of 10- dihydro- 10- deoxo- 11- asaeritronolides a
ES553821A0 (es) Un procedimiento para la preparacion de nuevas azetidinonas sustituidas.
FI90976C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten indolijohdannaisten ja niiden happoadditiosuolojen valmistamiseksi
DK588486A (da) Anvendelse af en forbindelse til behandling af hypoxi
NO170079C (no) Fremgangsmaate for fremstilling av et krystallinsk torasemid
FI850654L (fi) Menetelmä terapeuttisesti käyttökelpoisten pleuromutilinijohdannaisten valmistamiseksi
FI874459A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
NO874699D0 (no) Fremgangsmaate for frenstilling av nye substituerte cefalosporin-sulfoner.
ES555646A0 (es) Un procedimiento para producir derivados de 4-0-sulfonil-uracilo
BG44204A3 (en) Method for preparing of 2- oxyindol derivatives
BG50834A3 (en) Method for the preparation of 3- acyl- 2- oxindole- 1- carboxamides
GR1000316B (el) Μεθοδος για την παρασκευη μιας ενωσης με γαστρικη ανασταλτικη δραση.
FI893003A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
ES2038176T3 (es) Un procedimiento para la preparacion de derivados del naftaleno.
FR2355822A1 (fr) Derives d'esters de l'acide indolacetique. utiles comme anti-inflammatoires et analgesiques
FI861821A (fi) Nytt foerfarande foer optisk separation av racemiska blandningar av -naftylpropionsyror
IT7820500A0 (it) Prieta' analgesiche, antinfiammatocomposizioni farmaceutiche con prorie e inibitrici della sintetasi di prostaglandina
DK45486A (da) Anti-inflammatorisk praeparat
FI863471A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
GR1000887B (el) Νεα παραγωγα σπιροφουρανης.
ES547599A0 (es) Un procedimiento para preparar nuevos derivados de ciano-2- bencimidazol
BE850653A (fr) Nouvel inhibiteur de glyco-hydrolases et sa preparation par culture d'un streptomyces
ES2046528T3 (es) Derivados heterotetraciclicos de lactamas, proceso para su preparacion y composiciones farmaceuticas a base de los mismos.
FI893434A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sykloalkyylitiatsolijohdannaisten valmistamiseksi
FI92396B (fi) Uusi menetelmä valmistaa metyleenidioksifenantreeniyhdisteitä